SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Fidelity Select Sector funds

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dennis who wrote (153)9/15/1997 10:56:00 PM
From: Haolin Ni   of 4916
 
You know that the live attenuated vaccine could be reverted to virulent not to mention the normal side effect so the medical record is very important beside the vaccination normally covered by insurance company so the paper work is also important. Therefore, you know whether it could be taken home. It is just as not every drug could be used at home.

As I said a UK company is developing a dead flu vaccine which could be deliveried nosal as well. If it is a measle vaccine deliveried nosally would be great because the vaccinees could obtain life protection after immunized with a live attenuated measle vaccine but you could not get a life immunity after infected by flu virus so that such life attenuated vaccine is not as good as a dead flu virus vaccine.

Good luck!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext